Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 16/20 | 0.44 |
| ▸ | SRR | Q9GZT4 | 4/20 | 0.42 |
| ▸ | PPARG | P37231 | 11/20 | 0.42 |
| ▸ | PSAT1 | Q9Y617 | 2/20 | 0.41 |
| ▸ | PPARD | Q03181 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3963049 | 0.82 | PPARA (0.48) | PPARASRRPPARGPSAT1PPARD | |
| SCHEMBL6732246 | 0.82 | PPARA (0.48) | PPARASRRPPARGPSAT1PPARD | |
| SCHEMBL5689806 | 0.81 | PPARA (0.65) | PPARAPPARGPPARD | |
| SCHEMBL5365626 | 0.80 | PPARA (0.46) | PPARASRRPPARGPSAT1 | |
| SCHEMBL28341197 | 0.77 | ALDH1A1 (0.41) | — | |
| SCHEMBL4451913 | 0.77 | PPARA (0.47) | PPARAPPARG | |
| SCHEMBL5197835 | 0.77 | ALDH1A1 (0.44) | — | |
| SCHEMBL6396437 | 0.76 | PPARA (0.53) | PPARAPPARGPPARD | |
| SCHEMBL5365342 | 0.74 | PPARA (0.46) | PPARAPPARGPPARD | |
| SCHEMBL4907665 | 0.73 | ALDH1A1 (0.44) | PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7309720-B2 | 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders | ASTRAZENECA AB (SE) | 2007-12-18 | — | — | US | disclosed |
| US-20060178432-A1 | 2-Ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders | ASTRAZENECA AB (SE) | 2006-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178432-A1 | 2-Ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders | LIPC, PNLIP, CPT1A | PPARA 34/4885SRR 276/4885PPARG 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.